Genetic Technologies Ltd (GENE) — Capital Reinvestment Ratio
Genetic Technologies Ltd (GENE) has a Capital Reinvestment Ratio of 0.06x as of June 2011, meaning it reinvests 0% of its operating cash flow ($1.12 Million) in capital expenditures ($69.84K). Check Genetic Technologies Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genetic Technologies Ltd Capital Reinvestment Ratio (2007–2011)
This chart tracks Genetic Technologies Ltd's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Genetic Technologies Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for Genetic Technologies Ltd (2007–2011)
Year-by-year Capital Reinvestment Ratio for Genetic Technologies Ltd from 2007 to 2011. See cash generation quality of Genetic Technologies Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 0.06x | $2.23 Million | $139.68K | ▼ -77.6% |
| 2008 | 0.28x | $423.68K | $118.26K | ▲ +286.6% |
| 2007 | 0.07x | $2.20 Million | $158.87K | — |